MARATTO

article · Benha Journal of Applied Sciences

Different Modalities For Treatment Of Vitiligo

Abstract

Background: Vitiligo is a prevalent acquired disorder of pigmentation, affecting individuals globally. Numerous therapeutic modalities had been recommended for vitiligo such as phototherapy, topical and systemic corticosteroids, calcineurin inhibitors, vitamin D3 analogue derivatives, 5-flurouracil, laser therapy, and surgical techniques. However, there is no treatment to ensure complete cure of vitiligo, therefore, combination therapy is frequently recommended. Objectives: This article aims to review different modalities in treatment of vitiligo. Conclusions: Vitiligo treatment can sometimes be frustrating due to the inconsistency in clinical improvement and its relapsing feature. Therapy should be individualized according to the type of vitiligo, presence of activity and the side-effect profile of the drug used.Background: Vitiligo is a prevalent acquired disorder of pigmentation, affecting individuals globally. Numerous therapeutic modalities had been recommended for vitiligo such as phototherapy, topical and systemic corticosteroids, calcineurin inhibitors, vitamin D3 analogue derivatives, 5-flurouracil, laser therapy, and surgical techniques. However, there is no treatment to ensure complete cure of vitiligo, therefore, combination therapy is frequently recommended.

Research topics

  • melanin and skin pigmentation
  • Garlic and Onion Studies
  • Mast cells and histamine

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bjas.2024.321379.1504

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.